FDA Inspection
Aizant Drug Research Solutions Private Ltd.Aizant Drug Research Solutions Private Ltd. – FDA Inspection, Aug 18, 2017
Record Details
This FDA Inspection record concerns Aizant Drug Research Solutions Private Ltd., with an inspection on August 18, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- August 18, 2017
- Product Type
- Human Drugs
View Company Profile
ID · 642b4edc-2555-46cc-b2b6-2f8b05d46e56
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1022301
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.58Buildings not maintained in good state of repair
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aizant Drug Research Solutions Private Ltd.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| November 14, 2025 | Not classified | Office of Inspections and Investigations | |
| April 28, 2023 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| January 25, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 24, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aizant Drug Research Solutions Private Ltd.
- FDA Inspection 1328790 - 2026-07-31
- FDA Inspection 1301216 - 2025-11-14
- FDA Inspection 1207686 - 2023-04-28
- FDA Inspection 1198206 - 2023-01-25
- FDA Inspection 1115743 - 2020-01-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.